These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39002498)

  • 1. Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target.
    Matyskin AV; Angermeier SB; Drera SS; Prible MC; Geuther JA; Heibel MD
    Nucl Med Biol; 2024; 136-137():108940. PubMed ID: 39002498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective separation of radium and actinium from bulk thorium target material on strong acid cation exchange resin from sulfate media.
    McAlister DR; Horwitz EP
    Appl Radiat Isot; 2018 Oct; 140():18-23. PubMed ID: 29936271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theoretical model for the production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
    Melville G; Fan Liu S; Allen BJ
    Appl Radiat Isot; 2006 Sep; 64(9):979-88. PubMed ID: 16806950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.
    Soderquist CZ; McNamara BK; Fisher DR
    Curr Radiopharm; 2012 Jul; 5(3):244-52. PubMed ID: 22697483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
    Melville G; Meriarty H; Metcalfe P; Knittel T; Allen BJ
    Appl Radiat Isot; 2007 Sep; 65(9):1014-22. PubMed ID: 17532223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactor production of Thorium-229.
    Hogle S; Boll RA; Murphy K; Denton D; Owens A; Haverlock TJ; Garland M; Mirzadeh S
    Appl Radiat Isot; 2016 Aug; 114():19-27. PubMed ID: 27163437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclotron production of
    Nagatsu K; Suzuki H; Fukada M; Ito T; Ichinose J; Honda Y; Minegishi K; Higashi T; Zhang MR
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):279-289. PubMed ID: 34196752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclotron production of Ac-225 for targeted alpha therapy.
    Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
    Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories.
    Perron R; Gendron D; Causey PW
    Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other Metals.
    Fitzsimmons J; Foley B; Torre B; Wilken M; Cutler CS; Mausner L; Medvedev D
    Molecules; 2019 May; 24(10):. PubMed ID: 31109077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry at cellular level for the alpha-emitting radionuclides actinium-225, astatine-211 and radium-223 for bone metastasis cells from castration resistant prostate cancer.
    Oliveira-Silva CC; Maillard MS; Silva R; Sá LV
    Phys Med Biol; 2024 Oct; 69(20):. PubMed ID: 39284341
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of polydentate picolinic acid chelating ligands and an α-melanocyte-stimulating hormone derivative for targeted alpha therapy using ISOL-produced
    Ramogida CF; Robertson AKH; Jermilova U; Zhang C; Yang H; Kunz P; Lassen J; Bratanovic I; Brown V; Southcott L; Rodríguez-Rodríguez C; Radchenko V; Bénard F; Orvig C; Schaffer P
    EJNMMI Radiopharm Chem; 2019 Aug; 4(1):21. PubMed ID: 31659557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies.
    Abou DS; Zerkel P; Robben J; McLaughlin M; Hazlehurst T; Morse D; Wadas TJ; Pandya DN; Oyama R; Gaehle G; Nickels ML; Thorek DLJ
    Cancer Biother Radiopharm; 2022 Jun; 37(5):355-363. PubMed ID: 35695807
    [No Abstract]   [Full Text] [Related]  

  • 14. Actinium isotope cross sections for
    Horn D; Rand ET; Perron R; Abushusheh A; Facina M; Gendron D; McCaugherty K; Sheardown J
    Appl Radiat Isot; 2024 Oct; 212():111427. PubMed ID: 39182352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of actinium-225 for alpha particle mediated radioimmunotherapy.
    Boll RA; Malkemus D; Mirzadeh S
    Appl Radiat Isot; 2005 May; 62(5):667-79. PubMed ID: 15763472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of ion exchange and extraction chromatography to the separation of actinium from proton-irradiated thorium metal for analytical purposes.
    Radchenko V; Engle JW; Wilson JJ; Maassen JR; Nortier FM; Taylor WA; Birnbaum ER; Hudston LA; John KD; Fassbender ME
    J Chromatogr A; 2015 Feb; 1380():55-63. PubMed ID: 25596759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of radium and actinium using zirconia.
    Brown MA
    Appl Radiat Isot; 2022 Jul; 185():110238. PubMed ID: 35430492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-226.
    Melville G; Melville P
    Appl Radiat Isot; 2013 Feb; 72():152-7. PubMed ID: 23220026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radium-228 analysis of natural waters by Cherenkov counting of Actinium-228.
    Aleissa KA; Almasoud FI; Islam MS; L'Annunziata MF
    Appl Radiat Isot; 2008 Dec; 66(12):1954-63. PubMed ID: 18632278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides.
    Henriksen G; Schoultz BW; Michaelsen TE; Bruland ØS; Larsen RH
    Nucl Med Biol; 2004 May; 31(4):441-9. PubMed ID: 15093814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.